A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a complex, heterogeneous, and genetically unstable disease. Its tumor microenvironment (TME) is complicated by heterogeneous cancer cell populations and strong desmoplastic stroma. This complex and heterogeneous environment makes it challenging to discover and validate unique therapeutic targets. Reliable and relevant in vitro PDAC tumor models can significantly advance the understanding of the PDAC TME and may enable the discovery and validation of novel drug targets. In this study, an engineered tumor model is developed to mimic the PDAC TME. This biomimetic model, named ductal tumor-microenvironment-on-chip (dT-MOC), permits analysis and experimentation on the epithelial-mesenchymal transition (EMT) and local invasion with intratumoral heterogeneity. This dT-MOC is a microfluidic platform where a duct of murine genetically engineered pancreatic cancer cells is embedded within a collagen matrix. The cancer cells used carry two of the three mutations of KRAS, CDKN2A, and TP53, which are key driver mutations of human PDAC. The intratumoral heterogeneity is mimicked by co-culturing these cancer cells. Using the dT-MOC model, heterogeneous invasion characteristics, and response to transforming growth factor-beta1 are studied. A mechanism of EMT and local invasion caused by the interaction between heterogeneous cancer cell populations is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To address these challenges, a chip-based biomimetic ductal TME was developed to replicate the microanatomy of PDAC (Bradney et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“This model facilitated the exploration of varied local invasion patterns in response to TGF-β1 based on genotype and phenotype, as well as the investigation of heterogeneous interactions among diverse cancer cell populations (Bradney et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Murine pancreatic cancer cells from two genetically engineered mouse models, representing common PDAC mutations, were utilized—one with KRAS and TP53 mutations and the other with KRAS and CDKN2A mutations, displaying distinct mesenchymal and epithelial phenotypes.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“The model consisted of a duct lined with pancreatic cancer cell epithelium embedded in a collagen matrix, forming a perfusable epithelial lumen that mimicked physiological biomechanical forces.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936
Cancer modeling meets human organoid technology
Tuveson, D., & Clevers, H. (2019) · Science · doi:10.1126/science.aaw6985 · Cited by 935
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Stromal biology and therapy in pancreatic cancer
Neesse, A., Michl, P., Frese, K. K., Feig, C., Cook, N., Jacobetz, M. A., Lolkema, M. P., Buchholz, M., Olive, K. P., Gress, T. M., et al. (2011) · Gut · doi:10.1136/gut.2010.226092 · Cited by 757
Huang, L., Holtzinger, A., Jagan, I., BeGora, M., Lohse, I., Ngai, N., Nostro, C., Wang, R., Muthuswamy, L. B., Crawford, H. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3973 · Cited by 740
Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., Karikari, C., Alvarez, H., Iacobuzio-Donahue, C., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 694
The role of stroma in pancreatic cancer: Diagnostic and therapeutic implications
Erkan, M., Hausmann, S., Michalski, C. W., Fingerle, A. A., Dobritz, M., Kleeff, J., & Friess, H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.115 · Cited by 662
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Von Hoff, D. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 601
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
Morris, J. P., Wang, S. C., & Hebrok, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2899 · Cited by 567
A peek into cancer-associated fibroblasts: origins, functions and translational impact
LeBleu, V. S., & Kalluri, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.029447 · Cited by 537
The role of stromal cancer-associated fibroblasts in pancreatic cancer
von Ahrens, D., Bhagat, T. D., Nagrath, D., Maitra, A., & Verma, A. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0448-5 · Cited by 389
Chen, M. B., Whisler, J. A., Fröse, J., Yu, C., Shin, Y., & Kamm, R. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.018 · Cited by 385
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Muranen, T., Selfors, L. M., Worster, D. T., Iwanicki, M. P., Song, L., Morales, F. C., Gao, S., Mills, G. B., & Brugge, J. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.024 · Cited by 384
Sipos, B., Möser, S., Kalthoff, H., Török, V., Löhr, M., & Klöppel, G. (2003) · Virchows Archiv · doi:10.1007/s00428-003-0784-4 · Cited by 308
Seeley, E. S., Carrière, C., Goetze, T., Longnecker, D. S., & Korc, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1290 · Cited by 283
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer
Weigelt, B., & Bissell, M. J. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.013 · Cited by 273
Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels
Bischel, L. L., Young, E. W. K., Mader, B. R., & Beebe, D. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.005 · Cited by 265
3D Bioprinted in vitro metastatic models via reconstruction of tumor microenvironments
Meng, F., Meyer, C. M., Joung, D., Vallera, D. A., McAlpine, M. C., & Panoskaltsis‐Mortari, A. (2019) · Advanced Materials · doi:10.1002/adma.201806899 · Cited by 262
Genetically Engineered Models Have Advantages over Xenografts for Preclinical Studies
Becher, O. J., & Holland, E. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3827 · Cited by 243
Gress, T. M., Müller‐Pillasch, F., Lerch, M. M., Friess, H., Büchler, M., & Adler, G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620409 · Cited by 233
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
Singh, M., Lima, A., Molina, R., Hamilton, P., Clermont, A. C., Devasthali, V., Thompson, J. D., Cheng, J. H., Bou Reslan, H., Ho, C. C. K., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1640 · Cited by 215
Pancreatic Cancer Stroma: Friend or Foe?
Gore, J., & Korc, M. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.026 · Cited by 187
Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
Wang, S., Huang, S., & Sun, Y. (2017) · BioMed Research International · doi:10.1155/2017/2646148 · Cited by 174
Loukopoulos, P., Kanetaka, K., Takamura, M., Shibata, T., Sakamoto, M., & Hirohashi, S. (2004) · Pancreas · doi:10.1097/00006676-200410000-00004 · Cited by 172
Theocharis, A. D., Tsara, M. E., Papageorgacopoulou, N., Karavias, D. D., & Theocharis, D. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00051-x · Cited by 169
Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip
Kwak, B., Ozcelikkale, A., Shin, C. S., Park, K., & Han, B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.027 · Cited by 165
Self-citationDrifka, C. R., Tod, J., Loeffler, A. G., Liu, Y., Thomas, G. J., Eliceiri, K. W., & Kao, W. J. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.97 · Cited by 152
Pancreatic cancer stromal biology and therapy
Xie, D., & Xie, K. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.01.002 · Cited by 138
Development of an in Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer Drug
Shin, C. S., Kwak, B., Han, B., & Park, K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300595a · Cited by 135
Self-citationStromal reengineering to treat pancreas cancer
Stromnes, I. M., DelGiorno, K. E., Greenberg, P. D., & Hingorani, S. R. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu115 · Cited by 120
Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42
Razidlo, G. L., Burton, K. M., & McNiven, M. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003276 · Cited by 107
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1–Dependent Immune Evasion
Yang, Y., Stang, A., Schweickert, P. G., Lanman, N. A., Paul, E. N., Monia, B. P., Revenko, A. S., Palumbo, J. S., Mullins, E. S., Elzey, B. D., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3206 · Cited by 94
Self-citationChallenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models
HogenEsch, H., & Nikitin, A. Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.031 · Cited by 91
Ozcelikkale, A., Moon, H., Linnes, M., & Han, B. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1460 · Cited by 87
Self-citationMonti, P., Marchesi, F., Reni, M., Mercalli, A., Sordi, V., Zerbi, A., Balzano, G., Carlo, V. D., Allavena, P., & Piemonti, L. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1053-x · Cited by 76
Seo, B. R., DelNero, P., & Fischbach, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 74
Özçelikkale, A., Shin, K., Noe-Kim, V., Elzey, B. D., Dong, Z., Zhang, J., Kim, K., Kwon, I. C., Park, K., & Han, B. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.024 · Cited by 65
Self-citationShin, K., Klosterhoff, B. S., & Han, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00131 · Cited by 54
Self-citationSempere, L. F., Gunn, J. R., & Korc, M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.3.15979 · Cited by 52
Carpino, G., Renzi, A., Cardinale, V., Franchitto, A., Onori, P., Overi, D., Rossi, M., Berloco, P. B., Alvaro, D., Reid, L. M., et al. (2015) · Journal of Anatomy · doi:10.1111/joa.12418 · Cited by 52
Signaling Pathways in Pancreatic Cancer
Preis, M., & Korc, M. (2011) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i2.20 · Cited by 47
Khalafalla, F. G., & Khan, M. W. (2017) · Cancer Growth and Metastasis · doi:10.1177/1179064417709287 · Cited by 42
Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment
Obonai, T., Fuchigami, H., Furuya, F., Kozuka, N., Yasunaga, M., & Matsumura, Y. (2016) · Scientific Reports · doi:10.1038/srep23613 · Cited by 40
CHO, K., MATSUDA, Y., UEDA, J., UCHIDA, E., NAITO, Z., & ISHIWATA, T. (2012) · International Journal of Oncology · doi:10.3892/ijo.2011.1280 · Cited by 39
Baker, L. A., Tiriac, H., & Tuveson, D. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8879-2_9 · Cited by 35
Intratumoral phenotypic heterogeneity as an encourager of cancer invasion
Shin, Y., Han, S., Chung, E., & Chung, S. H. (2014) · Integrative Biology · doi:10.1039/c4ib00022f · Cited by 32
Driver mutations: A roadmap for getting close and personal in pancreatic cancer
Korc, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13128 · Cited by 31
Jakubison, B. L., Schweickert, P. G., Moser, S. E., Yang, Y., Gao, H., Scully, K. M., Itkin‐Ansari, P., Liu, Y., & Konieczny, S. F. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12314 · Cited by 31
Self-citationOtsuru, T., Kobayashi, S., Wada, H., Takahashi, T., Gotoh, K., Iwagami, Y., Yamada, D., Noda, T., Asaoka, T., Serada, S., et al. (2018) · Cancer Science · doi:10.1111/cas.13918 · Cited by 22
Stock, A.-M., Hahn, S. A., Troost, G., Niggemann, B., Zänker, K. S., & Entschladen, F. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.04.022 · Cited by 17
Cited by
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Wang, G., Zhang, C., Jiang, Y., Song, Y. H., Chen, J., Sun, Y., Li, Q., Zhou, Z., Shen, Y., & Huang, P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102786 · Cited by 99
Microfluidics meets 3D cancer cell migration
Mehta, P., Rahman, Z., ten Dijke, P., & Boukany, P. E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.006 · Cited by 85
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 50
Metadata
- Authors
- Bradney, M. J., Venis, S. M., Yang, Y., Konieczny, S. F., & Han, B.
- Affiliations
- Purdue University West Lafayette (US)
- Corresponding author
- Han, Bumsoo
- Venue
- Small
- Publisher
- Wiley
- Published
- 2020-01-30
- Volume
- 16
- Issue
- 10
- Pages
- e1905500-e1905500
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- PMC
- PMC7069790
- OpenAlex
- W3003341929
- Cited by
- 38
- References
- 63
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 3
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Small (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (U01 HL143403, UL1 TR002529, R01 CA211098, R01 CA124586)
- Purdue University Center for Cancer Research (P30 CA023168)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor microenvironment, organ-on-a-chip, epithelial-mesenchymal transition, local invasion, intratumoral heterogeneity, desmoplastic stroma, KRAS, CDKN2A, TP53, TGF-β1, collagen matrix
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasm Invasiveness, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Biomimetics, Microfluidics, Cell Line, Tumor, Mice, Epithelial-Mesenchymal Transition, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.